Completed NA INTERVENTIONAL 2-arm
NCT00463086
Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons (HAART-IPT)
A Randomized-controlled Trial of Isoniazid Plus Highly Active Antiretroviral Therapy Against Placebo to Prevent Tuberculosis in HIV-infected Persons
Sponsor: Imperial College London
Updated 1 time since 2024 Last updated: Jul 16, 2012 Started: Nov 30, 2007 Primary completion: Nov 30, 2011 Completion: Nov 30, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This NA trial investigates HIV Infections and Latent Tuberculosis Infection and is currently completed. Imperial College London leads this study, which shows 1 recorded version since 2007 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
1 version recorded Completed — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Imperial College London
- Johns Hopkins University
- London School of Hygiene and Tropical Medicine
- Medecins Sans Frontieres, Netherlands
- University of Cape Town
Data source: University of Cape Town
For direct contact, visit the study record on ClinicalTrials.gov .